Skip to content
Life Sciences Series A Founded 2015

Otolith Labs

Provider of a wearable platform for treating vertigo and motion sickness. The platform is meant for travelers and virtual reality users. The company leverages its proprietary technology for addressing the problem of the vestibular system and eye control balance which causes vertigo and motion sickness. The company was founded in 2015 and headquartered in Washington, United States. It has raised $33.8M in series a…

📍 Washington, DC, United States · ENT Disorders,

Funding snapshot

Last roundSeries A
Amount$5M
Date29 July 2024
Total raised$34M
Team size15

About

Provider of a wearable platform for treating vertigo and motion sickness. The platform is meant for travelers and virtual reality users. The company leverages its proprietary technology for addressing the problem of the vestibular system and eye control balance which causes vertigo and motion sickness. The company was founded in 2015 and headquartered in Washington, United States. It has raised $33.8M in series a funding, with backing from Morningside, MedTech Innovator. The company operates in the Life Sciences - ENT Disorders, High Tech - Wearable Technology space. The company leverages advanced technology to deliver innovative solutions tailored to its target market, addressing key industry challenges and driving value for its customers.

Business model

Wearable Technology > Health and Wellness Devices > Ear Care > Vertigo Treatment,

ENT Disorders > Medical Devices > Therapeutic Devices > Ear > Neurotology > Vertigo > Wearable

Founders & team highlights

Serial Founder

Institutional investors

Morningside MedTech Innovator Mark Cuban

Latest coverage

No articles yet.

Raising like Otolith Labs?

Analyze your pitch deck before your next raise.

Analyze My Deck →